Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
- PMID: 36609404
- PMCID: PMC9824968
- DOI: 10.1186/s13148-022-01405-5
Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
Figures
Erratum for
-
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.Clin Epigenetics. 2022 Nov 14;14(1):148. doi: 10.1186/s13148-022-01362-z. Clin Epigenetics. 2022. PMID: 36376973 Free PMC article.
References
-
- Bigouret V, Hoffmann T, Arlettaz L, Villard J, Colonna M, Ticheli A, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood. 2003;101:3198–3204. doi: 10.1182/blood-2002-08-2408. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
